An evaluation of fibrinolysin therapy in acute myocardial infarction.
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001780:Blood Coagulation Tests; D005260:Female; D005341:Fibrinolysin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis
D000925:Anticoagulants; D001219:Aspartate Aminotransferases; D005341:Fibrinolysin